About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Patients Under Gastroesophageal Reflux Disease Drugs Need To Manage Their Body Weight

by Aruna on October 27, 2009 at 9:31 AM
Font : A-A+

Patients Under Gastroesophageal Reflux Disease Drugs Need To Manage Their Body Weight

Long-term treatment with proton pump inhibitor might make patients with gastroesophageal reflux disease (GERD) fat, reveals a new study.

GERD is the most common esophageal disorder and frequently encountered in the primary care setting.

Advertisement

Accumulating evidence has confirmed the excellent efficacy and safety of proton pump inhibitor (PPI) therapy in patients with all grades of GERD, making these agents the mainstay of treatment.

However, the possible impact of changes in body weight (BW) or body mass index (BMI) in reflux patients while on long-term PPI therapy has not been examined.
Advertisement

During the study, 52 patients with GERD were treated with PPI for a mean of 2.2 years and also advised on lifestyle modifications (e.g. selective diet, weight management).

The researchers found that there was no difference in BW and BMI between reflux patients and controls at baseline.

Patients with GERD showed increases in BW, but no such changes were noted in the control group. Mean BW increased by 3.5 kg in 37 reflux patients but decreased in only 6 patients during treatment.

They concluded that reflux patients treated with a daily maintenance therapy of PPI should be strongly encouraged to manage their body weight through lifestyle modifications such as proper diet and avoidance of overeating.

The study is published in the World Journal of Gastroenterology.

Source: ANI
ARU
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Research News

 New Insights into How the Immune System Responds to Spinal-Cord Injuries
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
Nearsightedness: Atropine Eye Drops may Slow Progression in Kids
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune Diseases Affect One in Ten: Study
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Remarkable Journey of Transforming Lives With Brain Pacemaker
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
What Are the Effects of Healthy Lifestyle on Osteoarthritis?
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Patients Under Gastroesophageal Reflux Disease Drugs Need To Manage Their Body Weight Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests